Analysis of Radiolytically Generated Gases in Mini-AMORE Experiment
- Argonne National Lab. (ANL), Argonne, IL (United States)
Argonne National Laboratory (Argonne) is assisting one of the potential domestic Mo-99 producers, SHINE Medical Technologies, as part of the National Nuclear Security Administration’s (NNSA) Office of Material, Management, and Minimization (M3) program in the development of a domestic Mo-99 production pathway that does not use highly enriched uranium (HEU). The process proposed by SHINE would produce Mo-99 by neutron-induced fission of a low enriched uranium (LEU) solution as uranyl sulfate in a subcritical assembly. As part of the development effort, Argonne is undertaking the AMORE (Argonne Molybdenum Research Experiment) project, which is essentially a pilot facility for all phases of Mo-99 production, recovery, and purification. Mini-AMORE is a part of the AMORE experiment where 2 mL samples of uranyl sulfate solution are inserted in the dry well of the AMORE target solution vessel.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA), Office of Defense Nuclear Nonproliferation (NA-20). Office of Material Management and Minimization (M3)
- DOE Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1463259
- Report Number(s):
- ANL/CFC-18/3; 145486; TRN: US1901659
- Country of Publication:
- United States
- Language:
- English
Similar Records
Low LET Irradiations of Uranyl Sulfate Solutions in the Absence and Presence of Fe+2 and Fe+3 ions
Compendium of Phase-I Mini-SHINE Experiments